| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 03/29/2006 | EP1640007A1 Antiepileptic agent |
| 03/29/2006 | EP1638972A2 Novel crystalline forms of valacyclovir hydrochloride |
| 03/29/2006 | EP1102782B1 Structural analogs of amine bases and nucleosides |
| 03/29/2006 | CN1752087A Adenine kind derivative and its synthesis method |
| 03/29/2006 | CN1247579C Synthesizing nucleoside analog for antivirus |
| 03/29/2006 | CN1247578C Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |
| 03/28/2006 | US7019136 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors |
| 03/23/2006 | WO2006031505A1 Purine derivatives as a3 and a1 adenosine receptor agonists |
| 03/23/2006 | WO2006030906A1 Nucleoside analogues or salts thereof |
| 03/23/2006 | WO2006029769A1 Novel 3-methyl-7-butinyl-xanthines, production thereof, and use thereof as medicaments |
| 03/23/2006 | WO2006004884A3 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| 03/23/2006 | WO2005028434A3 Novel heterocyclic compounds as hsp90-inhibitors |
| 03/23/2006 | US20060063788 Carbon monoxide dependent guanylyl cyclase modifiers and methods of use |
| 03/23/2006 | US20060063787 Condensed imidazole derivatives |
| 03/23/2006 | CA2601996A1 Purine derivatives as a3 and a1 adenosine receptor agonists |
| 03/23/2006 | CA2576294A1 Novel 3-methyl-7-butinyl-xanthines, production thereof, and use thereof as medicaments |
| 03/22/2006 | EP1636231A2 2-amino-9-(2-substituted ethyl)purines and preparing methods for 9- 4-acetoxy-3-(acetoxymethyl)but-1-yl]- 2- aminopurine using the same |
| 03/22/2006 | EP1636230A2 A1 adenosine receptor antagonists |
| 03/22/2006 | EP1636229A2 A1 adenosine receptor antogonists |
| 03/22/2006 | EP1636216A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 03/22/2006 | EP1636189A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase |
| 03/22/2006 | EP1220862B1 Purine derivatives |
| 03/22/2006 | CN1751044A Sulfonamide substituted xanthine derivatives for use as PEPCK inhibitors |
| 03/16/2006 | WO2006029253A2 A valacyclovir impurity, process for the preparation of valacyclovir impurity and use as a reference standard |
| 03/16/2006 | WO2006027365A1 2-substituted-6-trifluoromethyl purine derivatives with adenosine-a3 antagonistic activity |
| 03/16/2006 | WO2006027204A1 8-(3-amino-piperidin-1-yl)-7-(but-2-inyl)-xanthines, production thereof and use thereof as medicaments |
| 03/16/2006 | US20060058323 New 8-(3-amino-piperidin-1-yl)-7-(but-2-ynyl)-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| 03/16/2006 | US20060058298 Inhibitors of histone deacetylase |
| 03/16/2006 | US20060058259 Human t-cell,lymphocyte virus; hepatitis virus |
| 03/16/2006 | DE102004044221A1 Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel New 3-methyl-xanthine-7-butynyl, their preparation and their use as medicaments |
| 03/16/2006 | DE102004038270A1 Substituierte, bizyklische 8-Amino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted bicyclic 8-amino-xanthine, processes for their preparation and their use as medicaments |
| 03/16/2006 | DE102004038269A1 Substituierte, bizyklische 8-Piperidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted bicyclic 8-piperidino xanthine, processes for their preparation and their use as medicaments |
| 03/16/2006 | DE102004038268A1 Substituierte, bizyklische 8-Pyrrolidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted bicyclic 8-pyrrolidino-xanthines, processes for their preparation and their use as medicaments |
| 03/16/2006 | DE102004037554A1 Substituierte 8-Aminoalkylthio-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted 8-aminoalkylthio-xanthines, processes for their preparation and their use as medicaments |
| 03/16/2006 | CA2579302A1 2-substituted-6-trifluoromethyl purine derivatives with adenosine-a3 antagonistic activity |
| 03/16/2006 | CA2575751A1 8-(3-amino-piperidin-1-yl)-7-(but-2-inyl)-xanthines, production thereof and use thereof as medicaments |
| 03/15/2006 | EP1633771A1 Macrolide-conjugates with anti-inflammatory activity |
| 03/15/2006 | EP1633753A1 Novel crystalline forms of valacyclovir hydrochloride |
| 03/15/2006 | EP1633746A1 New indole derivatives as factor xa inhibitors |
| 03/15/2006 | EP1408962B1 Substituted isoindoles and the use thereof |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | CN1747959A Process for preparing the antiviral agent [1s-(1alpha,3 alpha,4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6h-purin-6-one |
| 03/15/2006 | CN1745755A Nucleotide analog composition and synthesis method |
| 03/09/2006 | WO2006026115A2 Boot disk management utility |
| 03/09/2006 | WO2005092891A3 Preparation of esters of ganciclovir |
| 03/09/2006 | US20060052602 1-((3-(4-chlorophenyl)isoxazol-5-yl)methyl)-8-(2,3-difluorophenyl)-1H-purine, used treat or prevent viral infections such as hepatitis C virus (HCV) |
| 03/09/2006 | US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 03/09/2006 | US20060052403 Novel adenine compound and use thereof |
| 03/08/2006 | EP1234576B1 Pharmaceutical composition for eating disorders |
| 03/08/2006 | EP1176959B1 Novel prolines as antimicrobial agents |
| 03/08/2006 | CN1745080A 1,3-dihydroimidazole fused-ring compound |
| 03/08/2006 | CN1745063A Compound inhibiting dipeptidyl peptidase iv |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/08/2006 | CN1244376C Releasable bond and composition containing said bond |
| 03/07/2006 | US7008948 Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors |
| 03/02/2006 | DE102004039507A1 Substituierte 8-Aminoalkoxi-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted 8-Aminoalkoxi-xanthines, processes for their preparation and their use as medicaments |
| 03/01/2006 | EP1628967A1 Immunosuppressant compounds and compositions |
| 03/01/2006 | CN1740172A Abacavin preparing process |
| 02/28/2006 | US7005430 Such as (R)-2-cyclopentyl-7,8-dihydro-8-(4-picolyl)-4-(n-propyl)-1H-imidazo(2,1 -i)purin-5(4H)-one d-tartaric acid, which has glucose concentration-dependent insulin secretion promoting action/hypoglycemic activity; antidiabetic agents |
| 02/28/2006 | US7005425 Administering a minimal dose of an Al adenosine receptor agonist in conjunction with a minimal dose of a beta blocker, calcium channel blocker, or cardiac glycoside |
| 02/23/2006 | WO2006018117A1 Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments |
| 02/23/2006 | WO2005048953A3 Amide derivatives as kinase modulators |
| 02/23/2006 | CA2576561A1 Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments |
| 02/22/2006 | EP1626725A2 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
| 02/22/2006 | EP1224187B1 Certain alkylene diamine-substituted heterocycles |
| 02/21/2006 | US7002012 Therapeutic treatment of septic shock; chemical condensation reaction by cyclization, amidation, chemical intermediates |
| 02/21/2006 | US7001910 substituted pyrimidinyl-amino-ethoxy benzyl-thiazolidine-diones; hypoglycemic agents |
| 02/16/2006 | WO2005097135A3 Use of 9h-purine-2,6-diamine derivatives in the treatment of proliferative diseases and novel 9h-purine-2,6-diamine derivatives |
| 02/16/2006 | US20060036092 making 4(R)-[-2,6-diamino-purin-9-yl)-[1,3]-dioxolan-2(R)-yl]-methanol ( beta -D-DAPD); esterification, cyclization, selective reduction, purification |
| 02/16/2006 | CA2575904A1 Substituted 8-aminoalkylthio-xanthines, and the use thereof as inhibitors of the dipeptidyl peptidase iv |
| 02/15/2006 | EP1626049A1 Microcrystal |
| 02/14/2006 | US6998484 Nucleophile-induced intramolecular ring closure of the C-branched carbohydrate; higher overall yield |
| 02/14/2006 | CA2375385C Propargyl phenyl ether a2a receptor agonists |
| 02/09/2006 | WO2005105803A3 Purine derivatives as a1 adenosine receptor antagonists |
| 02/09/2006 | US20060030709 PNA monomer and precursor |
| 02/09/2006 | US20060030605 Pharmaceutical compounds |
| 02/09/2006 | US20060029663 Solid formulation |
| 02/08/2006 | EP1623223A2 Fluorescently tagged ligands |
| 02/08/2006 | EP1622908A1 Xanthine derivatives as a2b adenosine receptor antagonists |
| 02/07/2006 | US6995148 Hypotensive agents, vasodilation, antiischemic agents, cardiovascular disorders |
| 02/07/2006 | CA2262454C Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha. |
| 02/02/2006 | WO2006011874A1 Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
| 02/02/2006 | US20060025596 Method for deuteration or tritiation of heterocyclic ring |
| 02/02/2006 | US20060025425 Benzimidazole and pyridylimidazole derivatives |
| 02/02/2006 | US20060024775 Substrates for o6-alkylguanina-dna alkyltransferase |
| 02/02/2006 | CA2572268A1 Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
| 02/01/2006 | EP1620544A2 MODIFIED iRNA AGENTS |
| 02/01/2006 | EP1463707A4 A group of novel anti-cancer compounds with specific structure |
| 02/01/2006 | CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 01/31/2006 | US6992187 reacting 4,6-dichloro-5-nitropyrimidine with acyclic carboxy amines, then cyclization of the intermediates to form cellular adhesion inhibitors |
| 01/31/2006 | US6991902 Nucleobase heterocyclic combinatorialization |
| 01/26/2006 | US20060019996 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/24/2006 | US6989398 Benzanilides as potassium channel openers |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/19/2006 | WO2005095357A3 Pyrimidine derivatives and methods of treatment related to the use thereof |
| 01/19/2006 | US20060014760 Compounds and methods of use to treat infectious diseases |
| 01/19/2006 | US20060014748 2-NH-heteroarylimidazoles with antibacterial activity |
| 01/19/2006 | DE102004032263A1 New 7-butynyl-8-(3-amino-1-piperidinyl)xanthine derivatives useful as dipeptidyl peptidase IV inhibitors, e.g. for treating diabetes, arthritis, obesity and osteoporosis |
| 01/18/2006 | EP1615926A1 (purin-6-yl) amino acid and production method thereof |
| 01/18/2006 | CN1723207A Inhibitors of histone deacetylase |